Physician profile
Ryan Watson
NPI 1578977898
$20,758.53
in general payments reported to CMS, 2019-2025
32 companies · $3,676 in 2025
The $3,676 reported for 2025 was more than what 79% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $844 · 2020: $166 · 2021: $9,513 · 2022: $2,124 · 2023: $1,616 · 2024: $2,821 · 2025: $3,676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,409 · Travel and Lodging: $1,556 · Consulting Fee: $148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,408.65 |
| Travel and Lodging | $1,555.79 |
| Consulting Fee | $148.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $9,516.38 | 2021-2024 | Symplicity G3, Corevalve Evolut R |
| Abbott Laboratories | $2,528.94 | 2019-2025 | Triclip, Diamondback Coronary, Thoratec Heartmate 3 Lvas Implant Kit |
| Edwards Lifesciences Corporation | $1,838.53 | 2022-2025 | Evoque, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Philips North America LLC | $1,436.98 | 2019-2025 | Mcot |
| Abiomed | $1,157.16 | 2022-2025 | Impella |
| Amgen INC. | $455.54 | 2019-2025 | Repatha, Repatha |
| Heartflow, INC. | $448.41 | 2022-2025 | Ffrct |
| Cardiovascular Systems INC. | $414.52 | 2020-2023 | Diamondback Coronary |
| Shockwave Medical, INC | $404.73 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inari Medical, INC. | $375.05 | 2020-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $370.54 | 2022-2025 | Avvigo Guidance System |
| Novartis Pharmaceuticals Corporation | $180.78 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $180.00 | 2019-2024 | Lifevest |
| W. L. Gore & Associates, INC. | $149.67 | 2025 | Gore Cardioform Septal Occluder |
| Jenavalve Technology, INC. | $148.08 | 2024 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $142.93 | 2019-2024 | Xarelto |
| Kestra Medical Technology Services, INC. | $138.79 | 2022-2024 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $135.69 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $132.08 | 2019-2024 | Eliquis, Camzyos |
| Astrazeneca Pharmaceuticals LP | $125.16 | 2019-2025 | Farxiga, Brilinta, Wainua |
| Merck Sharp & Dohme LLC | $94.25 | 2022-2023 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $57.82 | 2022-2024 | Opsumit |
| Sanofi-Aventis U.S. LLC | $55.18 | 2023-2024 | |
| Pfizer INC. | $54.44 | 2020-2024 | |
| Scpharmaceuticals INC. | $39.04 | 2025 | |
| Cardiva Medical, INC. | $34.24 | 2023 | Cardiva Vascade 6/7f Vcs |
| Cordis US Corp. | $30.82 | 2022 | |
| Terumo Medical Corporation | $28.42 | 2020-2023 | Tr Band |
| Alnylam Pharmaceuticals INC. | $23.72 | 2025 | Onpattro |
| Penumbra, INC. | $21.59 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $20.34 | 2023 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $18.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.